Cathie Wood's Ark Invest Continues To Shed Coinbase, Nvidia Shares
Benzinga (Mon, 15-Apr 11:44 PM ET)
Teladoc Health to Announce First Quarter 2024 Financial Results
Globe Newswire (Fri, 12-Apr 8:30 AM ET)
Teladoc Health Board of Directors Announces Leadership Transition
Globe Newswire (Fri, 5-Apr 6:30 AM ET)
Teladoc Health to Participate in Upcoming Investor Conference
Globe Newswire (Fri, 8-Mar 8:30 AM ET)
Teladoc Health Expands Obesity & Weight Management Capabilities
Globe Newswire (Thu, 7-Mar 8:30 AM ET)
TDOC Bearish Calendar Put Spread Appears to be a Bargain at 48 Cents
Market Chameleon (Wed, 21-Feb 9:57 AM ET)
Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
Globe Newswire (Tue, 20-Feb 4:05 PM ET)
Globe Newswire (Mon, 19-Feb 8:00 AM ET)
Teladoc Health to Announce Fourth Quarter 2023 Financial Results
Globe Newswire (Thu, 1-Feb 8:30 AM ET)
Teladoc Health highlights progress in advancing care access, sustainability in new report
Globe Newswire (Thu, 18-Jan 9:00 AM ET)
Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Teladoc Health trades on the NYSE stock market under the symbol TDOC.
As of April 18, 2024, TDOC stock price climbed to $13.18 with 3,874,131 million shares trading.
TDOC has a beta of 2.05, meaning it tends to be more sensitive to market movements. TDOC has a correlation of 0.16 to the broad based SPY ETF.
TDOC has a market cap of $2.20 billion. This is considered a Mid Cap stock.
Last quarter Teladoc Health reported $661 million in Revenue and -$.17 earnings per share. This fell short of revenue expectation by $-11 million and exceeded earnings estimates by $.04.
In the last 3 years, TDOC stock traded as high as $192.11 and as low as $12.93.
The top ETF exchange traded funds that TDOC belongs to (by Net Assets): ARKK, VTI, VB, ARKG, VXF.
TDOC has underperformed the market in the last year with a price return of -49.1% while the SPY ETF gained +22.3%. TDOC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -32.2% and -8.5%, respectively, while the SPY returned +6.1% and -3.8%, respectively.
TDOC support price is $12.81 and resistance is $13.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TDOC stock will trade within this expected range on the day.